Abstract | INTRODUCTION: METHODS: This was a retrospective study that included all patients on renal replacement therapy (between 2008 and 2011) who had previously received calcium-based binders for ≥ 6 months and were subsequently switched to sevelamer. Data collected from the patients' medical records included demographics, as well as renal parameters three months prior to sevelamer treatment, and at three and six months post treatment. The study excluded patients on multiple, concomitant phosphate binders or with functioning renal transplants, and those who were noncompliant or had inadequate follow-up blood investigations. RESULTS: CONCLUSION:
|
Authors | Sartaj Alam, Asrar Hussain, Rajendra Daiwajna, Jackson Tan |
Journal | Singapore medical journal
(Singapore Med J)
Vol. 54
Issue 5
Pg. 263-6
(May 2013)
ISSN: 0037-5675 [Print] India |
PMID | 23716151
(Publication Type: Journal Article)
|
Chemical References |
- Chelating Agents
- Phosphates
- Polyamines
- Uric Acid
- Sevelamer
|
Topics |
- Adult
- Bone Diseases
(complications)
- Chelating Agents
(therapeutic use)
- Female
- Humans
- Hypercalcemia
(drug therapy)
- Hyperphosphatemia
(drug therapy)
- Kidney Failure, Chronic
(drug therapy)
- Male
- Middle Aged
- Phosphates
(chemistry)
- Polyamines
(therapeutic use)
- Renal Replacement Therapy
(methods)
- Retrospective Studies
- Sevelamer
- Treatment Outcome
- Uric Acid
(blood)
|